AU2003214645A1 - Long pentraxin ptx3 functional derivatives for preparing an autologous vaccine for the treatment of tumours - Google Patents

Long pentraxin ptx3 functional derivatives for preparing an autologous vaccine for the treatment of tumours

Info

Publication number
AU2003214645A1
AU2003214645A1 AU2003214645A AU2003214645A AU2003214645A1 AU 2003214645 A1 AU2003214645 A1 AU 2003214645A1 AU 2003214645 A AU2003214645 A AU 2003214645A AU 2003214645 A AU2003214645 A AU 2003214645A AU 2003214645 A1 AU2003214645 A1 AU 2003214645A1
Authority
AU
Australia
Prior art keywords
tumours
preparing
treatment
functional derivatives
long pentraxin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003214645A
Other languages
English (en)
Other versions
AU2003214645A8 (en
Inventor
Rita De Santis
Giovanni Salvatori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of AU2003214645A1 publication Critical patent/AU2003214645A1/en
Publication of AU2003214645A8 publication Critical patent/AU2003214645A8/xx
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/4756—Neuregulins, i.e. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2003214645A 2002-02-28 2003-02-25 Long pentraxin ptx3 functional derivatives for preparing an autologous vaccine for the treatment of tumours Abandoned AU2003214645A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT2002RM000109A ITRM20020109A1 (it) 2002-02-28 2002-02-28 Derivati funzionali della pentraxina lunga ptx3 per preparare un vaccino autologo per la cura dei tumori.
ITRM2002A000109 2002-02-28
PCT/IT2003/000104 WO2003072603A2 (en) 2002-02-28 2003-02-25 Long pentraxin ptx3 functional derivatives for preparing an autologous vaccine for the treatment of tumours

Publications (2)

Publication Number Publication Date
AU2003214645A1 true AU2003214645A1 (en) 2003-09-09
AU2003214645A8 AU2003214645A8 (en) 2003-09-09

Family

ID=11456119

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003214645A Abandoned AU2003214645A1 (en) 2002-02-28 2003-02-25 Long pentraxin ptx3 functional derivatives for preparing an autologous vaccine for the treatment of tumours

Country Status (12)

Country Link
US (1) US20090110666A1 (enExample)
EP (1) EP1478661A2 (enExample)
JP (1) JP2005538690A (enExample)
KR (1) KR20040099291A (enExample)
AR (1) AR038854A1 (enExample)
AU (1) AU2003214645A1 (enExample)
CA (1) CA2475526A1 (enExample)
IT (1) ITRM20020109A1 (enExample)
MX (1) MXPA04008217A (enExample)
PL (1) PL372719A1 (enExample)
TW (1) TWI293958B (enExample)
WO (1) WO2003072603A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20040858A1 (it) 2004-04-29 2004-07-29 Farma Dev S R L Anticorpi monoclonali ibridomi metodo migliorato per determinare la proteina ptx3 e kit per detta determinazione
ITRM20040489A1 (it) * 2004-10-08 2005-01-08 Sigma Tau Ind Farmaceuti Pentraxina lunga ptx3 deglicosilata o desialidata.
SI1973944T1 (sl) * 2006-01-24 2016-07-29 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. FGF2 vezavni peptidi in njihova uporaba
US9226960B2 (en) 2010-04-16 2016-01-05 Andrew B. Bush FGF modulation of in vivo antibody production and humoral immunity
US8435525B1 (en) * 2010-04-16 2013-05-07 Andrew B. Bush FGF modulation of in vivo antibody production and humoral immunity
TWI531375B (zh) 2015-05-29 2016-05-01 國立成功大學 抑制癌細胞活性之短肽治療劑及含此之醫藥組成物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849478A (en) * 1986-08-14 1998-12-15 Cashman; Daniel P. Blocked-polymerase polynucleotide immunoassay method and kit
US5290551A (en) * 1990-05-08 1994-03-01 Thomas Jefferson University Treatment of melanoma with a vaccine comprising irradiated autologous melanoma tumor cells conjugated to a hapten
IT1298487B1 (it) * 1997-12-19 2000-01-10 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale,
IT1317927B1 (it) * 2000-11-03 2003-07-15 Sigma Tau Ind Farmaceuti Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patologie autoimmuni.
IT1317930B1 (it) * 2000-11-08 2003-07-15 Sigma Tau Ind Farmaceuti Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patalogie associate ad una alterata attivazione
US20020122820A1 (en) * 2001-01-16 2002-09-05 Hildebrand William H. Soluble MHC artificial antigen presenting cells
AU2002324328B2 (en) * 2001-08-03 2007-09-06 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of long pentraxin PTX3 for treating female infertility
US7041648B2 (en) * 2001-08-03 2006-05-09 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Compositions and methods for treating female fertility
ITRM20020191A1 (it) * 2002-04-08 2003-10-08 Sigma Tau Ind Farmaceuti Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patologie tumorali associate ad una alterata att
US20040137544A1 (en) * 2002-10-31 2004-07-15 Roberto Latini PTX3 as an early prognostic indicator of cardiovascular and cerebrovascular pathologies
ITRM20030596A1 (it) * 2003-12-23 2005-06-24 Sigma Tau Ind Farmaceuti Uso di inibitori della pentraxina lunga ptx3, per la preparazione di un medicamento per la prevenzione e cura di patologie che rispondono all'inibizione dell'attivita' biologica di detta ptx3.
US20070023879A1 (en) * 2005-07-29 2007-02-01 Vinayak Pandey Single unit heat sink, voltage regulator, and package solution for an integrated circuit

Also Published As

Publication number Publication date
TW200303755A (en) 2003-09-16
EP1478661A2 (en) 2004-11-24
WO2003072603A2 (en) 2003-09-04
PL372719A1 (en) 2005-07-25
CA2475526A1 (en) 2003-09-04
WO2003072603A3 (en) 2004-03-18
US20090110666A1 (en) 2009-04-30
AR038854A1 (es) 2005-01-26
MXPA04008217A (es) 2004-11-26
WO2003072603A9 (en) 2004-10-07
AU2003214645A8 (en) 2003-09-09
KR20040099291A (ko) 2004-11-26
ITRM20020109A0 (it) 2002-02-28
ITRM20020109A1 (it) 2003-08-28
TWI293958B (en) 2008-03-01
JP2005538690A (ja) 2005-12-22

Similar Documents

Publication Publication Date Title
AP2005003283A0 (en) Indole derivatives useful for the treatment os diseases
IL189657A (en) Process for the preparation of n-phenyl-2-pyrimidine-amine derivatives
AU2003234597A1 (en) Drug therapy for celiac sprue
PL376454A1 (en) 1-acyl-pyrrolidine derivatives for the treatment of viral infections
AU2003232650A1 (en) N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
AU2003297199A8 (en) Human chondroitinase glycoprotein (chasegp), process for preparing the same, and pharmaceutical compositions comprising thereof
AU2003211453A1 (en) External compositions for the skin
AU2003290059A1 (en) Use of cd137 antagonists for the treatment of tumors
AU2003259145A1 (en) Treatment for dry eye syndrome
AU2003276129A1 (en) Compositions and methods for darkening the skin
AU2002219485A1 (en) An autologous anti-cancer vaccine
AU2003285320A1 (en) Vaccine
AU2003289603A1 (en) Tumor vaccine
AU2003214645A1 (en) Long pentraxin ptx3 functional derivatives for preparing an autologous vaccine for the treatment of tumours
AU2003223538A1 (en) Methods for the treatment of cancer
AU2003226899A1 (en) Human diabetes-mediating proteins
AU2003258529A1 (en) Use of lignans for prevening or treating the sings of ageing of the skin
AU2003209648A1 (en) Subunits of the adenovirus fiber protein and uses thereof as vaccines
AU2002304883A1 (en) Device for the treatment of tumours
AU2003296242A1 (en) Thia-epothilone derivatives for the treatment of cancer
AU2003201853A1 (en) Skin preparations for external use
AU2003276424A1 (en) Substituted pyrido-pyridazine derivatives which enhance cognition via the gaba-a receptor
AU2002354943A1 (en) Haptenizing cancer cell components for the preparation of cancer vaccines
AU2003900767A0 (en) Idiotypic vaccine
GB0308691D0 (en) Vaccine preparations

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase